Skip to main content

Home/ Cancer/ Group items tagged Centres

Rss Feed Group items tagged

Matti Narkia

New Evidence Points To An Overlooked Risk Factor For Cancer: Acetaldehyde In Alcohol - 0 views

  •  
    New evidence by researchers at the Centre for Addiction and Mental Health (CAMH) and researchers in Germany shows that drinking alcohol is the greatest risk factor for acetaldehyde-related cancer. Heavy drinkers may be at increased risk due to exposure from multiple sources.
Matti Narkia

pure sodium dichloroacetate - the way it should be - pureDCA.com - 0 views

  •  
    Sodium dichloroacetate offered by PureDCA.com has more than 99% purity. We make it using a sophisticated synthesis process. No organic solvents are used during the production. We are currently the only providers of sodium dichloroacetate, which is equivalent in quality to NaDCA used in Medicor Cancer Centres. We ship internationally, with no exceptions. We are the only source of sodium dichloroacetate, which attaches a chemical analysis to every shipment, free of charge. The only place you can order our sodium dichloroacetate is the Cancer Virtual Community Store - Buy Sodium Dichloroacetate.
Matti Narkia

Common diabetes drug may 'revolutionize' cancer therapies - 1 views

  •  
    Researchers at McGill University and the University of Pennsylvania have discovered that a widely used anti-diabetic drug can boost the immune system and increase the potency of vaccines and cancer treatments. Their findings will be published June 3 in the journal Nature. The discovery was made by Dr. Russell Jones, an assistant professor at McGill's Goodman Cancer Centre and the Department of Physiology, Faculty of Medicine, Yongwon Choi, PhD, professor of pathology and laboratory medicine, and postdoctoral fellow Erika Pearce, PhD, of the University of Pennsylvania. They discovered that the widely prescribed diabetes treatment metformin increases the efficiency of the immune system's T-cells, which in turn makes cancer and virus-fighting vaccines more effective.
Matti Narkia

Medicor Cancer Centres - DCA Therapy - 0 views

  •  
    For the first time in the world, on December 7, 2007 we publicly shared our observational data from the treatment of 118 cancer patients with DCA. In March 2008 we updated our data from treating over 175 patients. As of August 2008, we have treated over 265 cancer patients with DCA. Results of the analysis of our latest data are very similar to our two earlier reports.
1 - 4 of 4
Showing 20 items per page